Lupin Limited has informed the Exchange regarding a press release dated December 21, 2020, titled "Lupin Receives Approval for Rufinamide Oral Suspension.".
Press Release Dec 21 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Press Release Dec 18 2020
- Press Release Dec 16 2020
- Press Release Dec 01 2020
- Press Release Nov 25 2020
- Press Release Nov 12 2020
Later from Lupin
- Press Release Dec 24 2020
- Press Release Dec 28 2020
- Press Release Dec 29 2020
- Press Release Jan 06 2021
- Press Release Jan 07 2021
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin